ICMR BULLETIN VOL. 25-No. 2-FEBRUARY-1995
Item
- Title
- ICMR BULLETIN VOL. 25-No. 2-FEBRUARY-1995
- extracted text
-
ISSN 03774910
ICMR
BULLETIN
February, 1995
Vol. 25, No. 2
ZINC STATUS OF INDIAN CHILDREN
Zinc is a trace element, essential for human health.
It is a cofactor for more than 200 metalloenzymes thus
regulating various cellular metabolic activities and
physiological functions of the body. As an essential
metal required for protein and DNA synthesis and for
expression of the biological activity of thymulin (the
thymic derived hormone), zinc plays an important role
in growth and development and regulation of cell mediated
immune response.
Severe deficiency of this micronutrient is known to
cause a clinical syndrome in children characterised by
extreme degree of stunting, hypogonadism, anaemia,
anorexia and hepatosplenomegaly
*
. Though such a se
vere form of nutritional zinc deficiency is reported from
Egypt and countries of the Middle East, this is not a
common clinical problem in India. Nevertheless, in
populations that subsist on meagre diets which are also
of poor quality, it is possible for the deficiency to exist
in subclinical forms. Though the existence of zinc defi
ciency and its functional significance are not established,
zinc supplements are often prescribed to children on the
presumption that such supplements improve growth and
immune function. In fact, it has been demonstrated clearly
that zinc supplements confer no additional benefits to an
individual whose zinc status is already normal. On the
contrary, inadvertent zinc supplements can disturb the
delicate homeostasis of the trace element nutriture parti
cularly affecting the iron and copper status2. Therefore
studies were carried out at the National Institute ofNutrition
(NIN), Hyderabad, to see if the problem of zinc deficiency
exists in our population and whether there is a need for
routine zinc supplementation.
Assessment of Zinc Status in Children
The extent ofthe problem of subclinical zinc deficiency
has not been defined, probably due to the lack of a suitable
marker. In studies reported till recently, plasma zinc levels
are used to assess the zinc stores of the body. However,
plasma zinc is known to fluctuate with factors like infec
tions and diet and hence is not regarded as a useful marker3.
Leukocyte zinc levels are less fluctuant and are widely used
to assess zinc status. Changes in zinc status are known to
alter the biochemical functions of several enzymes and
hormones to which zinc is a cofactor. Estimation of alkaline
phosphatase and other enzymes .were attempted to define
zinc status. However, due to lack of specificity and inability
ofthese enzymes to reflect early changes in zinc status, they
were not uscfiil. Recent studies indicate that serum thymulin
activity is a sensitive indicator of early zinc deficiency4
This parameter, coupled with the conventional parameters
like leukocyte and plasma zinc were used in recent studies
at the NFN to assess the zinc status of children aged 1-5
years5. The zinc status of the children was related to their
nutritional status. Nine normals, 56 undernourished and 38
children with severe clinical protein energy malnutrition
(PEM) were investigated. In a subsample of 25 children,
Division of Publication & Information, ICMR, New f)e 1 hi 七 1 10 029
serum thymulin activity was determined. Activation of
thymulin was also carried out by in vitro addition of zinc
chloride, using standard methodology, to delineate the,effects
of PEM per se from those of zinc deficiency on the activity
of thymulin.
too
0
X
E
n
s
s
?xxx
XXXXX
Q
X
*
xxxxxxxx
so-j
Norma!
Under
nourished
s
=
8
o
o
<
6
r
y
9AU0W1
jo
2 o
u
O
J
d Neat M
NDJ
X
xxxx
CLc
u
o
J
g
c
60 a
u
u
o
W u
u
£
z
20
c
o
w
s
-SO
O
O
E
S
S
Z5O1
0
Severe
PEM
ND - Not Detectable
Fig.l. Mean leukocyte, plasma zinc and thymulin
activity in relation to nutritioinal status
of response could probably be interpreted as unmasking of
a relative zinc deficient status by activating the thymulin
which probably remained in an inactive form due to a
relative deficiency of zinc, in these children and hence
could be used as a sensitive parameter to detect very mild
forms of zinc deficiency. The biological significance of
such a mild zinc deficiency is, however, not known and
furthermore, the assay of senim thymulin is a cumber
some procedure and cannot be carried out to screen the
population fbr zinc deficiency. Under these circum
stances, leukocyte zinc levels, particularly if carried out
14
o
o
u
o.j
d
g
j
xlhymuhn activity
-par/
三
saj
o
X
u
=
n
u
j
>ȣ
OLeukocyte Zn
U W E A 二U u r u u s
• Plasma Zn
S
Y
-
二
Normal and undernourished children were found to
have satisfactory leukocyte and plasma zinc levels while
children with severe PEM had significantly lower levels
showing that severe deficiency. of zinc is part of the
syndrome of severe PEM. Serum thymulin was undetect
able in these children which could not be raised even
by in vitro addition of zinc chloride (Figs. 1 and 2) indi
cating that the thymic dysfunction observed could be pri
marily due to PEM per se. Children with undemutrition,
however, showed significant rise of thymulin activity over
basal levels following in vitro addition of zinc. This type
in homogenous populations of leukocytes and platelets,
yield useful information in assessing the zinc status of an
apparently normal population.
UN = UndernourFsedj ND-Not Detectable.
x* =P< 0.025 compared to Basal Thymulin Activity
1 = Mol Significant
Fig.2. In vitro addition of zinc chloride and thymulin
activity
Apart from identifying the marker to define the zinc
status of children, the NIN study suggests that there is no
significant problem of zinc inadequacy in the apparently
normal children in the community.
Role ofZinc Supplements in Rehabilitation of Children
with Severe PEM
Though zinc status of children suffering from severe
PEM is significantly low, the need if any, for routine zinc
supplementation in the rehabilitation ofchildren with severe
PEM, is not clear. This aspect was investigated with the
help of a double blind controlled study on 33 children
suffering from clinical forms of severe PEM6. The children
were randomly allocated into two groups, one which re
ceived 40 mg of zinc as zinc sulphate while the other had
placebo during the rehabilitation period of 3-4 weeks in
addition to the diet containing about 150-200 calories and
3-4 g protein/kg body weight/day. Both the groups received
similar supportive therapy. The leukocyte and plasma zinc
levels were determined initially at the time ofadmission and
at the end of rehabilitation. The children were closely
monitored for daily weight gain, food intake, disappearance
of oedema, duration of morbidity due to infection and
serum albumin regeneration. No differences were observed
in the clinical and biochemical parameters studied in the
16 children who received zinc supplements and the 17
children who received placebo.
All the children had significantly lower levels of leu
kocyte and plasma zinc levels at the time of admission
compared to 34 normal children who were simulta
neously investigated. At the end of rehabilitation, both
the zinc supplemented and placebo groups of children
demonstrated significant increase in the leukocyte zinc
levels comparable with the levels observed in normal
children. However, children on placebo experienced a
fall in plasma zinc levels which remained at significantly
lower levels than normals even at the end of the reha
bilitation period. In contrast, the supplemented children
had increased plasma zinc levels that were comparable
with levels in normal children.
This study showed that supplementation of zinc in
addition to adequate diet did not have additional benefits
on the clinical or biochemical responses However, the
difierential behaviour of plasma zinc in the two groups of
children is interesting. Plasma zinc is a measure of critical
balance between zinc supply and zinc demand. Fall in
plasma zinc levels in unsupplemented children, at a time
when they were experiencing rapid weight gain and tissue
deposition during rehabilitation, suggests the relative inad
equacy of zinc supply through diet alone to replenish their
deficient zinc status. The dietary zinc level of the children
was 7.3 mg per day which closely compared with the level
reported in literature based on dietary analysis and also to
the recommended dietary allowances (RDA) per day for
mineral elements for children below 5 years of age. T^e
study indicates that the dietary zinc is perhaps adequate to
bring about clinical res-ponse, though it is inadequate to
replenish the zinc stores of the deficient children.
It is known that zinc is essential for laying down muscle
mass and zinc deficient children have more adipose tisane
than muscle7. Hence it is possible that the type of tissue
deposited in zinc supplemented children could be different
from the placebo group of children. Therefore, it may be
useful to supplement zinc to children with severe PEM
which would not only improve their zinc status but could
also affect their body composition favourably.
Zinc Status of Pregnant Women and Newborns
It is believed that relative zinc deficiency occurs during
periods of increased physiological demands like pregnancy
and lactation and during situations of rapid growth like the
immediate post natal period when zinc supplements could
be useful, though there are no controlled studies to prove
the need for increased intakes. Data available on zinc status
of pregnant women and newborns are based on estimations
of plasma zinc which is not a suitable parameter for as
sessing zinc status8-9
In a recently conducted survey, by workers at the NIN,
it was found that 70 per cent of practising obstetricians and
pediatricians prescribed zinc supplements routinely to pregnant
women and to the newborns, particularly to infants with
low birth weight. Justification for such prescription needs
to be established with the help of controlled studies using
better markers for assessing zinc status in view of the
adverse effects ofunnecessary administration ofzinc supple
ments. In a recent study at the NIN, leukocyte and plasma
zinc levels were determined in 33 women who delivered at
term and 30 at preterm10. Maternal and cord blood samples
were collected at the time of delivery; Gestational ages and
birth weights of the babies were determined soon after
delivery and body mass index (BMI) of mothers was also
determined.
The results showed that both the leukocyte and plasma
zinc levels of mothers were lower than the corresponding
cord blood values, irrespective of birth weight or gestational
age of the newborn. They also had no relation to BMI.
Mothers with BMI of 12.0 to 18.5 and 18.5 to 25.0 had
leukocyte zinc levels (^g/1010 cells) of 63.3 and 79.3
respectively while the respective plasma concentrations
(/zg/dl) were 93.4 and 88.6.
Leukocyte zinc levels of preterm infants (213.6) were
significantly higher than those observed in full term infants
with a propriate or low birth weight (131 and 119 respec
tively). Plasma zinc levels of preterm infants were also
higher than in the other two groups but the differences were
not of statistical significance.
The study showed that, maternal zinc status has no
effect on birth weight. Zinc status of the infant is also
15
not related to the birth weight suggesting that zinc alone
is unlikely to regulate foetal growth which is a complex
process governed by several factors. Zinc status of the
newborns is, however, closely related to the gestational age.
The premature newborns seem to have an advantage of
better leukocyte zinc concentrations which perhaps could
be utilised during the rapid postnatal growth period.
These studies indicate that routine zinc supplements to
undernourished pregnant women or to newborns are unnec
essary.
Zinc Status of Infants in relation to Their Diets
Zinc deficiency is very rare among breast-fed infants.
However, some recent reports indicate the need for routine
zinc supplements to young infants with the presumption of
preventing growth faltering1 \ These studies are not based
on any biochemical evidence of zinc deficiency in breast
fed infants nor its inadequacy in breast milk and yet they
recommend the single nutrient supplementation. In view of
the potential adverse efiects of routine administration of
zinc to healthy infants, a cross sectional study was carried
out to examine the zinc status of infants bom at term and
preterm12.
Besides determining the zinc status of the infants at
birth and at 3 monthly intervals till one year of age,
breast milk zinc concentration was also estimated at
different periods of lactation. Twenty six of the Rill term
infants who were solely fed formula milk from birth were
also examined along with determination of zinc concen
trations of the formulae used (unpublished data). All
the infants were adequately and appropriately weaned
between 4-6 months.
The leukocyte and plasma zinc levels of the fiill term
and preterm breast-fed and the full term formula fed
infants at different ages are presented in Fig.3 and zinc
levels of breast milk in Fig.4. Both the full term and
preterm infants showed a decline in zinc status between
4-6 months of age which gradually improved by 9
months. The zinc levels at 9 months were comparable
to those at 1 year of age. Such decline in the status of
various nutrients is commonly observed at the age of 4-6
months marking the need fbr commencement of weaning.
After appropriate weaning, the zinc status reached normal
levels thus suggesting that the decline at 4-6 months is only
a physiological and transient phenomenon fbr which the
solution is proper weaning rather than single nutrient supple
mentation. Preterm infants also followed the same trend.
16
■ Plasma Zink (pg/dO
*P<0.05 PT Vs FT；**P<0.025; FF Vs BE
PT-Preterm； FT- Full term* FF - Formula fed.
BF-Breast-led
Fig.3. Zinc levels in full term, preterm and top fed
infants at different age periods
・ PT Vs FT ;
Milk
P< 0.05.
Fig.4. Zinc levels in breast milk
Zinc levels in colostrum were high and declined as
lactation progressed in both term and preterm mothers.
However, the latter had higher levels throughout lactation
thus perhaps meeting the higher requirements ofthe preterm
infants.
Formula fed infants, however, showed significantly low
levels of zinc at 3 months of age which became normal
following weaning. The formula milk contained zinc in
higher levels than mature milk of term mothers. However,
the low zinc levels of formula fed infants suggest that either
the zinc from the formula is not bioavailable or the formula
is not fed adequately or both. Though the period of poor
zinc status in these infants is transient, it is severe. These
babies might require zinc supplements.
Thus, studies at NIN on the zinc status of pregnant
women and children indicate that zinc deficiency is not
a significant problem and routine zinc supplements to
pregnant women, newborns or to breast-fed infants are
not necessary.
4.
Prasad, A.S.» Meftah, S , Abdallah, J., Kaplan, J., Brwer, GJ,
Bach, J.F. and Dardenne, M. Serum (hymuhn in human zinc
deficiency. J Clin Invest 82: 1202, )988.
5.
Hemalaiha, P.,Bhaskaram, P. Qadri, S.S.Y.H andAjeyakumar,
P. Assessment of mild zinc deficiency in children. Nutr Res
13: 115, 1993.
6.
Hemalatha, P.t Bhaskaram, P. and Khnn, M.M. Role of zinc
supplementation in rehabilitation of severely malnourished
children. Eur J Clin Nutr 47: 397, 1993.
7.
Golden, M.H.N. and Golden, B.E. Effect of zinc supplemen
tation on the dietary intake, rate of weight gain and energy
cost of tissue deposition in children recovering from severe
malnutrition. Am J Clin Nutr 34: 900, 1981.
8.
Prasad, L.S.N., Ganguly, S.K. and Vasuki, K. Role of zinc in
fbetal nutrition. Indian Pediatr 11: 799, 1974.
9.
Bogden, J.D., Thind, I.S., Kemp, F. W and Caterini, H. Plasma
concentrations of calcium, copper, iron, magnesium and zinc
in maternal and cord blood and their relationship to low birth
weight J Lab Clin Med 92: 455, 1978.
10. Islam, A., Hemalatha, P.» Bhaskaram, P. and Ajeyakumar, P.
Leukocyte and plasma zinc in maternal and cord blood. Their
relationship io period of gestation and birth weight. Nutr Res
14: 353, 1944.
References:
1.
McClain, C.J., Kasarskis Jr., E J. and Allen, JJ. Functional
consequences of zinc deficiency. Prog Food Nutr Sci 9: 185,
1985.
2.
Solomons, N.W. On the assessment of zinc and copper nutriture
in man. Am J Clin Nutr 32: 856, 1979.
3.
Aggett, P.J., Crofton, R.W., Khin, C., Grozdanovic, S. and
Grozdanovic, D. The mutual inhibitory effects on their
bioavailability of inorganic zinc and iron. Prog Clin Biol Res
129: 117, 1983.
11. Walravcns, P.A., Chakar, A., Mokni, R.» Denise, J. and
Lemonnicr, D. Zinc supplements in breast-fed infants. Lancet
340: 683, 1992.
12. Bhaskaram, P., Hemalatha, P. and Islam, A Zinc status in
breasl-ied infants. Lancet 340: 1416, 1992.
This write-up has been adapted from the article entitled "Is
zinc deficiency in children a nutritional problem lin India?”，
byP. Bhaskaramand P. Hemalatha, published in the Nutrition
News 15(2), 1994.
ABSTRACTS
Some Research Projects Completed Recently
Study of a possible link between smoking and pulmonary
tuberculosis.
The study was carried out in Municipal Wards 10
and 11 of the old city of Delhi (approximate population
40,000) to determine whether the prevalence of pulmo
nary tuberculosis among adult smokers in a general
population was significantly higher than in a corre
sponding group of non-smoking adults.
A complete census of the entire population of the
area was carried out on specially designed census
registers. Besides the identifying particulars, informa
tion on age, sex and smoking habits and nature of
smoking were also collected. Persons in the age group
of 15 years^.and above were subjected to 70 mm chest
X ray. Those with radiographic abnormalities were
subjected to bacteriological examination including sputum/
laryngeal swab examination by direct microscopy and
culture. Where indicated, repeat bacteriological and
radiological examinations were carried out to establish
a diagnosis.
Of the 24064 persons in the age group of 15 years
and above only 19399 (80.6%); 10057 males and 9342
females, could be studied. Overall 26.0 per cent of
males were smokers, 2.4 per cent ex-smokers and 71.6
per cent non-smokers. As the prevalence of smokers
among females was only 0.6 per cent, further analysis
was confined only to males. The proportion and inten
sity of smoking increased with increase of age.
Among the 10057 males, 162 (1.61 %) patients with
active pulmonary tuberculosis, of whom 54 (0.54%)
were bacteriologically proven, were found. The overall
prevalence of active pulmonary tuberculosis in smok
ers, ex-smokers and non-smokers was 3.26, 3.29 and
0.96 per cent respectively. The corresponding rates for
bacteriologically proven pulmonary tuberculosis were
1.9, 1.23 and 0.28 per cent. After standardisation for
age it was found that 2.43 per cent of the smokers were
suffering from pulmonary tuberculosis (1.03% of the
ses being bacillary cases). The corresponding figures
fbr non-smokers being 1.07 per cent (0.32% bacillary
cases). The differences are statistically significant.
A *trend test
*
also revealed that the prevalence of
pulmonary tuberculosis increased with the intensity of
the smoking.
Govind Prasad
New Delhi Tuberculosis Centre
New Delhi.
Immunopathogenetic role of food antigens in
rheumatoid arthritis.
Fifty patients with rheumatoid arthritis (RA) were
studied to determine whether food related antigens
caused exacerbation and their removal caused remission
in the inflammatory activity in RA. This was done in
order to see if this dietary elimination technique could
become one of the adjuctive techniques and whether it
could be predicted as to which patient would respond
to this therapy and to which of the food item(s). Patients
receiving any disease modifying drugs or having taken
corticosteroids were excluded from the study.
The patients were subjected to dietary modification
therapy. This comprised a protein free diet of salads,
fruits, vegetables, sugar and oils for 2 weeks. Patients
who responded to this dietary elimination were then
allowed step-wise dietary addition. Seventeen of the 50
patients (34%) responded to diet elimination and showed
decreased synovitis. Only 10 of these 17 patients could
be followed up in the dietary addition phase. Six of
them were intolerant to one of three dietary items (one
to milk, two to rice and three to wheat), two were
intolerant to more than one dietary items (both milk
and wheat caused flare in these two) and two patients
were intolerant to some food items which could not be
identified. Wheat, milk, and rice were found to be the
common offending dietary items causing flare up of the
synovitis.
Analysis of relative risk for the various HLA antigens
revealed that RA patients carrying HLA DR1 pheno
type had over 26 times more chance of responding to
diet elimination compared to those without DR1.
Similarly RA patients carrying DR5 had 2.75 times
higher chances of responding to diet elimination than
those without this antigen. Nonspecific inflammatory
immunoglobulin levels, immune complex levels,
lymphoproliferative response and anti-fbod item anti
bodies did not show any correlation with response to
dietary elimination.
Patients with active rheumatoid arthritis showed
decreased lymphoproliferative response both to specific
antigens as well as nonspecific mitogens. They also
showed perturbed ratio between 'naive' and 4memory
*
CD4 + subset of helper lymphocytes. Those who res
ponded to dietary elimination showed a trend of this
ratio to revert towards normal levels. High levels of
anti-food item antibodies seen in RA patients could be
related to .the increased gut permeability in patients
with rheumatoid arthritis. Those who showed response
to dietary elimination also showed a fall in the IgA class
of anti-fbod antibodies indicating that, somehow their
gut permeability could have improved.
A.N. Malaviya
Department of Medicine
All India Institute of Medical Sciences
New Delhi.
18
ICMR NEWS
The following meetings of various technical groups/
committees of the Council were held:
PAC on District Level
Project for Control of
Cervical Cancer
January 23, 1995
Meetings of theScientific Advisory Committees (SACs)
of the ICMR Institutes/Centres:
PAC on Tobacco Economics
January 24, 1995
TF on Drug Delivery
System fbr Contraceptives
January 25, 1995
PAC on Collaborative Study
on Coronary Heart Disease
February 1, 1995
PAC on Integrated Delivery
of Reproductive Health care
at District Level
February 6-7, 1995
Centre for Advanced Research
for Bone Marrow Transplantation
for Thalassaemia, Vellore
January23,1995
(at Vellore)
Regional Medical Research
Centre, Bhubaneswar
February 13, 1995
(at Bhubaneswar)
Malaria Research Centre,
Delhi
February 15, 1995
(at Delhi)
Meetings of Scientific Advisory Groups (SAGs)/Project
Advisory Committees (PACs)/Project Review
Committees (PRCs)ZTask Forces (TFs) held at New
Delhi:
PRC on ICRC Leprosy
Vaccine Trial
January 16, 1995
PRC for Projects on
Non-Communicable Diseases
January 17, 1995
SAG of the Division of
Publication and Information
January 18, 1995
Participation of ICMR Scientists in Scientific Events:
Dr. G.V. Satyavati, Director-General, ICMR, de
livered the Prof. C. Dwarkanath Memorial Lecture as
part of the National Symposium on Charak Samhita at
Varanasi (February 1, 1995).
Dr. V.P. Sharma, Director, Malaria Research Cen
tre, Delhi, participated in the Commonwealth Secre
tariat Expert Group meeting on Health Impact Assess
ment within Environmental Impact Assessment at Aberdeen
(February 1-3, 1995).
Dr. S.P. Pani, Dy. Director, Vector Control Re
search Centre, Pondicherry, participated in the II meeting
of the WHO Steering Committee on Applied Field
Research at Geneva (February 6-10, 1995).
INDIAN COUNCIL OF MEDICAL RESEARCH
AWARDS AND PRIZES 1994
The Indian Council of Medical Research invites nominations/applications from Indian scientists fbr its various
prizes and awards in the field of Biomedical Sciences. Application forms and other relevant information can
be obtained from the Director-General, Indian Council of Medical Research (Indo-fbreign Cell), Ansari Nagar,
New Delhi-110029.
Nominations and completed applications should reach this office on or before 30th June 1995.
1. Basanti Devi Amir Chand Prize (Value = Rs.5,000):
This prize will be awarded annually to a senior research worker of more than ten years standing for work
of outstanding merit in any subject in the field of '-iomedical science, including clinical research: The term
uClinical Researchw implies research into the mechanism and causation of disease, including its prevention and
cure. The criteria for award of the prize are the significance ana value of addition to existing knowledge contributed
19
by a worker in a particular field in which he/she has been actively engaged over a number of years and has
shown sustained activity in research..
The selection for this prize is made one .year in advance.
2. Dr.P.N.Raju Oration Award (Value = Rs.5,000):
This prize will be awarded in alternate years, to an eminent scientist, preferably a medical person, for his/
her work in any subject of national importance in the field of Medicine or Public Health. The subject will
be notified at the time of advertisement. The subject for 1994 is “Tuberculosis".
3. Sandoz Oration Award for Research in Cancer (Value = Rs.2,500):
This prize (and a medal) will be awarded in alternate years, to an eminent scientist for outstanding work
carried out on a particular aspect of Cancer. The eminence is to be judged on the basis of his/her contributions
to cancer research which should have been recognised nationally and internationally and helped towards control,
prevention and cure of cancer.
4. Dr.Y.S.Narayana Rao Oration Award in *
Microbiology
(Value = Rs.4,000):
This prize will be given in alternate years, to an eminent scientist fbr outstanding work carried out in the
field of Microbiology. The criterion fbr award of the prize is the significance and value of addition to existing
knowledge contributed by a worker in Microbiology in which he/she has been actively engaged over a number
of years and has shown sustained activity in research.
5. Chaturvedi Kalawati Jagmohan Das Memorial Award (Value = Rs.2,000):
This prize (and a gold medal) will be awarded once in three years, to an eminent scientist, preferably a
medical person, for his/her work in the field of Cardiovascular Diseases. The criterion fbr award of the prize
is the significance and value of addition to existing knowledge contributed by a worker in Cardiovascular Diseases
in which he/she has been actively engaged over a number of years and has shown sustained activity in research.
6. Dr.Kamala Menon Medical Research Award (Value = Rs.5,000):
This prize will be awarded to an eminent scientist, preferably a medical person, for outstanding contribution
made in the field of Internal Medicine and Paediatrics respectively in alternate years. The criterion for award
of the prize is the significance and value of addition to existing knowledge contributed by a worker on a subject
in which he/she has been actively engaged over a number of years and has shown sustained activity in research.
The subject for 1994 is "Internal Medicine".
7. Kshanika Oration Award to a Woman Scientist for Research in the field of Biomedical Sciences
(Value = Rs.5,000):
This prize will be given annually to an eminent woman scientist for outstanding work carried out in any
branch of biomedical science, contributing to the alleviation of human suffering. The criterion fbr award of
this prize is the significance and value of addition to existing knowledge contributed by her in any field of
biomedical sciences in which she has been actively engaged over a number of years and has shown sustained
activity in research.
*This Award/Prize is not being awarded for the year 1994
20
8.
Dr.M.K.Seshadri Prize in the field of - Practice of Community Medicine (Value = Rs. 10,000):
This prize (and a gold medal) will be awarded in alternate years, to an eminent scientist or institution whose
original work has led to useful inventions in or otherwise significantly contributed to the Practice of Community
Medicine.
9.
M.N.Sen Oration Award for Practice of *
Medicine
(Value = Rs.5,000):
This prize will be given once in three years, to an eminent scientist for outstanding work carried out in
the field of Practice of Medicine (clinical, laboratory or therapeutic). The criterion for award of the prize
is the significance and value of addition to existing knowledge contributed by a worker to the practice of medicine
in which he/she has been actively engaged over a number of years and has shown sustained activity in research.
10. J ALM A Trust Fund Oration Award in the field of Leprosy (Value = Rs .5,000):
This prize (and a medal) will be given annually to an eminent scientist for outstanding research in the field
of Leprosy. The criterion for award of the prize is the significance and value of addition to existing knowledge
contributed by a worker on any aspect of leprosy in which he/she has been actively engaged over a number
of years and has shown sustained activity in research.
11. Dr.J.B.Srivastav Award in the field of *
Virology
(Value = Rs.10,000):
This prize will be given in alternate years, to an eminent scientist for outstanding work carried out in the
field of Virology. The criterion for award of the prize is the significance and value of addition to existing knowledge
contributed by a worker in Virology in which he/she has been actively engaged over a number of years and
has shown sustained activity in research.
12. ICMR Prize for Biomedical Research for Scientists belonging to Under-privileged Communities
(Value = Rs.5,000):
This prize will be given annually to an eminent scientist for his/her outstanding contributions in any field
of Biomedical Sciences. The criterion fbr award of the prize is the significance and value of addition to existing
knowledge contributed by a worker in the particular field in which he/she has been actively engaged over a number
of years and has shown sustained activity in research. This prize will be awarded to scientists belonging to
under-privileged communities.
13. ICMR Prize for Biomedical Research conducted in Under-developed Areas (Value = Rs.5,000):
This prize will be awarded annually to an eminent scientist for his/her outstanding contributions in any field
of Biomedical Sciences. The criterion for award of the prize is the significance and value of biomedical research
carried out by a worker based in under-developed parts of the country, or for work carried out in under
developed parts of the country over a period of five years preceding the year fbr which the award is to be
given.
14. BGRC Silver Jubilee Oration Award (Value = Rs.5,000):
,
This prize will be given in alternate years, to an eminent scientist for outstanding work carried out in the
Held of Haematology/Immunohaematology. The criterion for award of the prize is the significance and value
of addition to existing knowledge contributed by a worker in this speciality in which he/she has been actively
engaged over a number of years and has shown sustained activity in research.
*This Award/Prize is not being awarded for the year 1994
21
15. Smt.Swaran Kanta Dingley Oration *
Award
(Value = Rs.10,000):
This prize will be given in alternate years, to an eminent scientist fbr outstanding contribution in the field
of Reproductive Biology. The criterion fbr award of the prize is the significance and value of addition to existing
knowledge contributed by a worker in the field of Reproductive Biology in which he/she has been actively engaged
over a number of years and has shown sustained activity in research.
16. Dr.M.O.T.Iyengar Memorial Award (Value = Rs.4,000):
This prize will be given annually to an eminent scientist for outstanding contribution in the fields of Malaria,
Filariasis, Plague or Medical Entomology. The criterion for award of the prize is the significance and value
of addition to existing knowledge contributed by a worker in any of the fields of Malaria, Filariasis, Plague
or Medical Entomology in which he/she has been actively engaged over a number of years and has shown sustained
activity in research.
17. Prof.B.K.Aikat Oration *
Award
(Value = Rs.3,000):
This prize will be given in alternate years, to an eminent scientist fbr outstanding work carried out in the
field of Tropical Diseases. The criterion for award of the prize is the significance and value of addition to
existing knowledge contributed by a worker in Tropical Diseases in which he/she has been actively engaged
over a number of years and has shown sustained activity in research.
18. Dr.Vidya Sagar *
Award
(Value = Rs.5,000):
This prize will be awarded in alternate years, to an eminent scientist fbr outstanding contributions made
in the field of Mental Health. The criterion for award of the prize is the significance and value of addition
to existing knowledge contributed by a worker in Mental Health in which he/she has been actively engaged
over a number of years and has shown sustained activity in research；
19. Amrut Mody-Unichem Prize (Value = Rs.10,000):
This prize will be given to an eminent scientist for outstanding work carried out in the field of Cardiology
& Neurology,.and Gastroenterology (in alternate years). The criterion fbr award of the prize is the significance
and value of addition to existing knowledge contributed by a worker on a subject in which he/sKe has been actively
engaged over a number of years and has shown sustained activity in research. The subject for 1994 is "Cardiology
& Neurology
.
**
20. Amrut Mody-Unichem Prize (Value = Rs. 10,000):
This prize will be given to an eminent scientist for outstanding work carried out in the field of Maternal
& Child Health, and Chest Diseases in alternate years. The criterion fbr award of the prize is the significance
and value of addition to existing knowledge contributed by a worker on the subject in which he/she has been
actively engaged over a number of years and has shown sustained activity in research. The subject for 1994
is uChest Diseases
.
**
21. Chaturvedi Ghanshyam Das Jaigopal Memorial Award (Value = Rs.3,000):
This prize will be given in alternate years, to an eminent scientist for outstanding work carried out in the
field of Immunology. The criterion for award of the prize is the significance and value of addition to existing
knowledge contributed by a worker on the subject in which he/she has been actively engaged over a number
of years and has shown sustained activity in research.
♦This Award/Prize is not being awarded fbr the year 1994
22
22. Lala Ram Chand Kandhan Award (Value = Rs.5,000):
This award will be given in alternate years, to an eminent scientist for outstanding research in the fields
of Dermatology and Sexually Transmitted Diseases. The criterion for award of the prize is the significance
and value of addition to existing knowledge Contributed by a worker on the subject in which he/she has been
actively engaged over a number of years and has shown sustained activity in research.
23. Dr.Prem Nath Wahi Award for Cytology and Preventive *
Oncology
(Value = Rs.30,000):
This award will be given in alternate years, to an eminent scientist for outstanding contribution in the field
of Basic and/or Clinical Cytology, and/or Preventive Oncology. The criterion fbr award is the significance
and value of addition to existing knowledge contributed by a worker on the subject in which he/she has been
actively engaged over a number of years and has shown sustained activity in research.
24. Dr.D.N.Prasad Memorial Oration *
Award
(Value = Rs.20,000):
.This award (and a medal) will be given in alternate years, to an Indian scientist fbr significant contribution
to research in the field of Pharmacology, carried out in India, as evidenced by research papers and innovations.
The criteria for award will be the significance and value of addition to existing knowledge in research in
Pharmacology.
25. Prof.Surindar Mohan Marwah Award .(Value = Rs.25,000):
This award will be given once in 3 years to an Indian scientist fbr significant contribution in the field of
Geriatrics, through sustained research in India on the problems of the aged as evidenced by research papers
in science publications. The subject matter could be biomedical or psychosocial research on problems of the
aged, both basic and applied.
Award/Prize for Scientists above 45 years of age on January 1st of the year for which this
award is being given
26. Smt.Pushpa Sriramachari *Award (Value = Rs.5,000):
This prize (and a silver medal) will be given in alternate years, to individuals fbr outstanding contribution
to research on "Pathology and Pathophysiology ■ Clinical or Experimental". The individual should be an
established scientist above the age of 45 years and should have made a comprehensive and significant original
contribution in unravelling the understanding and the nature, evolution or prevention of any human disease entity.
Awards/Prizes for Young Scientists below 40 years of age on January 1st of the year for which
these awards are being given
27. Shakuntaia Amir Chand Prizes (Four in Number of Value = Rs.l9500 each):
These four prizes will be awarded annually to the best published research work in any subject in the field
of Biomedical Science including clinical research. The term 'Clinical Research
*
covers research into the
mechanism and causation of disease and its prevention and cure, and includes work on patients in hospitals,
field studies in epidemiology and social medicine, and observations in general practice.
*This Award/Prize is not being awarded fbr the year 1994
23
Both medical as well as non-medical graduates are eligible for award of the prize. The prizes are awarded
to Indian nationals for work done in any institution in India. Work started in India but completed abroad
will not be acceptable.
Papers published in Indian or Foreign Journals in the previous two years will be considered for award of
these prizes in the current year.
28. Raja Ravi Sher Singh of Kalsia Memorial Cancer Research Award (Value = Rs£,000):
This prize will be awarded in alternate years, to a scientist fbr outstanding work done in the experimental
or clinical aspects of cancer or in the organisation and conduct of any service or service-cum-research
programme in cancer prevention and treatment. For the prize to be awarded in the current year the work
carried out in the previous year will be considered.
29. Dr.V.N.Patwardhan Prize in Nutritional Sciences (Value = Rs.7,000):
This prize will be given in alternate years, to an eminent scientist, for outstanding work carried out in India
on fundamental, clinical or field studies in Nutritional Sciences. The criterion fbr award of prize is the
contribution of a worker to nutritional sciences -in which he/she has been actively engaged over a number of
years and has shown sustained activity in research.
30. Tilak Venkoba Rao Award (Value = Rs.1,000):
This prize will be given to an eminent scientist for research in the field of Psychological Medicine and
Reproductive Physiology respectively in alternate years. The criterion fbr the award is the significance of
contribution to existing knowledge by a worker who has been actively engaged in research on
the subject over a number of years. The subject for 1994 is MPsychological Medicine”.
31. Dr.T.Ramachandra Rao *
Award
(Value = Rs.3,000):
This prize will be given in alternate years, to a scientist below the age of 40 years for his/her outstanding
contribution made in the field of Medical Entomology. The criterion for award of the prize is the significance
and value of addition to existing knowledge contributed by a worker in this speciality in which he/she has been
actively engaged over a number of years and has shown sustained activity in research.
32. Dr.C.G.S.Iyer Oration *
Award
(Value = Rs.1,500):
This prize will be given in alternate years, to a scientist below the age of 40 years fbr his/her outstanding
contribution made in the field of Leprosy. The criterion fbr award of the prize is the significance and value
of addition to existing knowledge contributed by a worker in this speciality in which he/she has been actively
engaged over a number of years and has shown sustained activity in research.
33. Dr.Dharamvir Datta Memorial Oration Award (Value = Rs.3,000):
This award will be given in alternate years, to a scientist (Medical or non-medical) below 40 years of age
for work carried out in the last 5 years in India in the field of Liver Diseases. The criteria include significance
and value of addition to existing knowledge contributed by a worker in this speciality, with special reference
to application of findings to clinical hepatology.
*This Award/Prize is not being awarded for the year 1994
24
34. Prof.B.C.Srivastava Foundation Award (Value = Rs.5,000):
This award will be given in alternate years, to a scientist below the age of 40 years for work in the field
of Community Medicine in medical colleges/recognised institutions. The criterion for the award is the
significance of research contributions to the practice of community medicine by a worker.
35. Smt. Kamal Satbir Award (Value = Rs.5,000):
This award will be given annually to individuals for outstanding contribution to research on non-tuberculous
Chest Diseases, especially Respiratory Allergy and Chronic Obstructive Lung Diseases, pertaining to
mechanism and causation of the diseases, their prevention and/or management.
The work to be assessed would be the research carried out in India and published in scientific journals during
the three years preceding the year for which the award is to be given.
36. M^jor General Saheb Singh Sokhey Award (Value = Rs.10,000):
This award will be given annually to a scientist below the age of 40 years for his/her outstanding contribution
in the Held of Communicable Diseases depending upon its significance and value in terms of addition to existing
knowledge contributed by the worker in that field. The facets of work to be considered could be basic or applied
research which add to the knowledge on the mechanism and causation of communicable diseases, their prevention
and/or their management. The work to be assessed would be the research carried out in India and published
in scientific journals, during the 3 years preceding the year for which the award is to be given.
37. Dr.H.B.Dingley Memorial Award (Value = Rs.5,000):
This award will be given annually to individuals fbr outstanding contribution to research in the field of
'Paediatrics' by Indian scientists below the age of 40 years. The work to be assessed would be research work
carried out in India and published in scientific journals during the 3 years preceding the year fbr which the
award is to be given.
彳------------------ ---------------- Dr. B.R.Ambedkar Centenary Award for Excellence in
Biomedical Research (Value Rs. 1.00 lakh)
Dr. B.R.Ambedkar Centenary Award for excellence in biomedical research was
instituted in the year 1991-92 as part of the Dr. Ambedkar Birth Centenary
Celebrations. The award, of value rupees one lakh, is to be awarded in alternate
years, for excellence in any field of biomedical research, as evidenced by scientific
publications in internationally recognised journals, and contribution to advancement
of knowledge and/or improvements in medical practices, health programmes etc.
This Award is open to all age groups.
Direct applications are not accepted for this Award. Only nominations by certain
categories of people will be considered. Details are available in a separate brochure,
which is available on request.
I - --
-
----- ---
J
25
HOW TO APPLY
Applications/nominations should provide the names and other particulars of the candidates for award of the
prizes to the Council in the prescribed proforma.
Five copies (Ten copies in the case of the Basanti Devi Amir Chand Prize) of each of the following documents
will have to be sent with the application:
1.
The proforma for application/nomination with the details duly completed.
2. A note giving full details of the outstanding research contribution of the nominee or applicant which makes him/
her worthy of the award.
3.
A short biographical sketch of the candidate.
4. A list of papers published by the candidate giving details of those published in Indian and Foreign Journals separately,
and also indicating whether the journals are indexed or not.
5. Five reprints each of five recent significant papers published on the subject of the award by the applicant/nominee
(for the Basanti Devi Amir Chand Prize, ten reprints of each paper are required).
The applications for Shakuntala Amir Chand Prize should be sent along with ten copies each of the following
documents.
1.
The proforma for application/nomination with the details duly completed.
2. Reprints of the papers submitted for the prize.
3.
A note giving details of research work done by the candidate.'
4.
A list of papers published giving details ofthose published in Indian and Foreign Journals separately, and also indicating
whether the journals are indexed or not.
5,
A short biographical sketch of the candidate.
一
............ ............................. ..
....................
Nomination for Dr. B.R. Ainbedkar Centenary Award for
Excellence in Bio-Medical Research should be in the separate
format prescribed. Direct applications will not be entertained
for this Award.
•
--
............ .
一
26
TERMS & CONDITIONS OF ICMR AWARDS/PRIZES
1.
Only work published in Scientific (Scholarly) Journals will be considered fbr ICMR Awards.
2.
Normally work done during the preceding five years on the subject will be considered (except where otherwise
indicated, under “Detailed information on the ICMR prizes/awards)".
3.
If a scientist has received an ICMR award earlier fbr a particular subject, the same materia) will not be
considered for another ICMR award, unless there is evidence that additional work has been done. As such,
those applicantsAiominees who have received an ICMR award previously, should clearly indicate the additional
work done by them and provide reprints of subsequent publications, in support of such a claim.
4.
Only applications/hominations which are complete in all respects will be considered. Five sets of documents
(10 in case of Basanti Devi and Shakuntala Amir Chand Prizes) should be submitted, each set containing
one copy of the documents indicated in the Section "How to Apply". If sets received are not complete,
the application/nomination will not be considered.
5.
While the applicants/nominees do not need to provide " No Objection Certificates" from co-authors (since
1990 onwards), in the event of any dispute, the onus will be on the applicant/nominee/recipient of an ICMR
Award or Prize, and the ICMR will not be responsible fbr any such dispute arising out of counter-claims.
6.
The nominations/applications complete in all respects and with all the required documents should reach the
Council not later than 30th June, 1995 for ICMR Awards/Prizes fbr the year 1994.
JOINT APPLICATIONS
In the case of joint applications/publications, the prizes shall be divided
between the applicants/authors in such proportion as the Selection Board may
decide. The role of the individual who applies for the prize should be clearly
indicated so as to make it easy to determine whether major part of the work
has been done by that person. A certificate from the Senior Author that the
candidate applying for the award has himself/herself made significant contri
bution to the research work fbr which his/her paper is being recommended for
the award should also be submitted along with the application.
27
FORMAT FOR FURNISHING RELEVANT INFORMATION
ABOUT THE NOMINEE/APPLICANT
Name of Award Applied for
1.
Name of the Nominee/applicant:
2. a) Date of birth and age as on 1st
b)
January of the year for
which
the award is being
applied fbr:
Sex:
3. Academic qualifications beginning with the Bachelor's degree:
4. Present employment and posts held previously:
5. Details of outstanding research achievements, during the last five years:
6. Whether the achievements have been recognised/awarded by any learned society/i.nstitution (if so brief outline
to be given)
7. Number of scientific papers published,and reprints of those papers to be considered fbr the present application:
8. Subject of research work presented for the award:
9. Whether you have received
(i) Name
any award earlier fbr the same work or paper, if so, give the following:
(ii) Year
(iii) Value of award and
(iv) Exact caption of work fbr which the prize was awarded:
10. Give names and designations of all the joint authors, If any, on the work/paper(s) submitted for the award:
11. State whether for the same work/paper(s) any of the joint authors have received any award. If so,give the
name of the prize awarded, year of award and its value:
•12. If you are a joint author, state precisely what has been your individual contribution to the work:
13. State whether you have now applied fbr any other award for the same or any other work.
name of the award and the subject of work submitted fbr the award:
If so, state the
14. (i) List of papers, if any, submitted earlier fbr any other award and (ii) List of papers published subsequently
and now submitted for consideration of the award:
15
Address for correspondence:
NOTE: Applicants for the ICMR Prize for Biomedical Research for Scientists belonging to
Underprivileged Communities should provide attested Caste/Community certificates.
28
ICMR AIDED SYMPOSIA/SEMINARSAVORKSHOPS/COURSES/CONFERENCES
Symposium/SeminarAVorkshop/
Cou rse/Conference
Date & Place
Contact Address
Workshop on Techniques in Human Cytogenetics.
January 20-February 29；
1995;
(at Bangalore)
Dr. I. Manorama Thomas, Professor and Head,
Department of Anatomy and Division of Hun)af)
Genetics, St. John's Medical College, Bangalore.
February 3-5» 1995;
(at Bangalore)
Dr. H.R. Rajmohan, Organising Secretary of the
Conference, Regional Occupational Health Centre
VL National Conference on Occupational Health
and Safety.
(South), Library and Infbimation Block, Medical
College Campus, Banglore.
National Symposium on Cancer Research: Bridging
the Gap between Laboratory and Clinic and XTV
February 6-8, 1995;
(at Shillong)
Dr. R.H. Duncan Lyngdohv Convener of the
Conference, Department of Chemistry, North-Eastern
Hill University, Shillong.
VII National Conference of All India Rhinology
February 7-8,1995;
Society and Functional Endoscopic Sinus Surgery
(at Sevagram)
Dr. V.N. Chaturvedi, Organising Secretary of the
Conference, Department of ENT, Mahatma Gandhi
Institute of Medical Sciences, Sevagram, Wardha.
Annual Conference of the Indian Association for
Cancer Research
Workshop.
VIH Biennial Conference of the Indian Society of
Medical and Paediatric Oncology and International
February 9-11, 1995;
(at Indore)
Dr. Dinesh Pendharkar, Organising Secretary of the
Conference, B.D. Singhal Cancer Detection and
Prevention Centre, Roberts Nursing Home Campus,
Indore.
Symposium on Primary Chemotherapy.
XIX National Conference of Indian Association for
Febmary 11-12, 1995;
Dr. Bhushan Kumar, Organising Secretary of the
Study of Transmitted Diseases and AIDS.
(at Chandigarh)
Conference,
Department
of
Dermatology,
Ven
ereology and Leprosy, Postgraduate Institute
Medical Education and Research, Chandigarh.
of
Indo U.S. Conference on Receni Advances in
February 11-12,1995
Dr.
Pulmonology and Tuberculosis.
(at New Delhi)
Conference, Department of Pediatrics, Maulana Azad
K.
Chopra,
Organising
Secretary
of
the
Medical College, New Delhi.
bitemational
Seminar
on
Environment,
*
Sus
tainable Development and Human Health.
Singh,
of the
Seminar,
February 1145, 1995;
Prof
(at Varanasi)
Department of Geography, Banaras Hindu University,
Onkar
Convener
Varanasi.
XVHI Annual Conference of the Indian Society of
February 13-15,1995;
Dr. Rakesh Tuli, Convener of Conference, National
.Cell Biology and Cell Biology Symposia.
(at Lucknow)
Botanical Research Institute, Lucknow.
International Symposium on Neurointensive Care
Febniary 19, 1995;
and Neuroanaesthesia.
(at New Delhi)
Dr. H.H. Dash, Organising Secretaiy of the
Symposium,
Department
of Neuroanaesthesia,
Neurosciences Centre, All India Institute of Medical
Sciences, New Delhi.
Ashok Rattan, Organising
February 21-27,1995;
(at New Delhi)
Dr.
I Congress of Federation of Indian Physiological
March.1-3,1995;
Societies (FIPS).
(at New Delhi)
Dr.
W.
Selvamurthy,
Chairman,
Organising
Committee of the Congress, Defence Institute of
Workshop
on
Bacteria
causing
Molecular
Finger
Nosocomial
Printing
of
Infections:
Its
Application to Trace Source of Infection.
Secretary of the
Workshop, Department of Microbiology, All India
Institute of Medical Sciences, New Delhi.
Physiology and Allied Sciences, Delhi.
National Conference on Adolescent Health-cumWorkshop on AIDS/HIV Infection Prevention
amongst Adolescent and Youth.
March 4-5,1995
(at New Delhi)
Dr. Prema Bali, President, Indain Association for
Adolescent Health, A-5, Greater Kailash-II, New
Delhi.
29
Symposium/SeminarAVorkshop/
Cou rse/Conference
Date & Place
Contact Address
IV Convention of Indian Society of Agricultural
March 20-21, 1995;
Dr.
Biochemists and Symposium on Recent Deve
(at Varanasi)
Convention, Department of Biochemistry, Faculty of
Science, Banaras Hindu University, Varanasi.
March 25-27, 1995;
Dr. S.K. Gakhar, Organising Secretary of the
Symposium, Department of Biosciences, Maharishi
Dayanand University, Rohtak.
lopments in Biochemistry
XI
National
Symposium
on
Developmental
Biology.
(at Rohtak)
R.S.
Dubey,
Organising
Secretary
of the
COUNCIL'S TRAIMNG PROGRAMMES FOR 1995-96
Leprosy
Annual Training Course in Nutrition (December 1,
1995 ■ February 28, 1996).
•
At the Central Jalma Institute for Leprosy, Agra:
•
Multidrug Therapy Orientation Course in Leprosy for
Medical Officers (February 6-18, 1995).
Virology
Oncology
At the Institute of Cytology and Preventive Oncology,
New Delhi:
•
Workshop on Research Methods relating to Oncological
Studies with Computer Application (Febraruy 12-16,
1995).
•
Workshop on Molecular Biology ofVi ruses and Cancer
alongwith Oligo DNA Synthesis and Polymerase Chain
Reaction (September 18-22, 1995).
At the National Institute of Virology, Pune:
•
Diploma in Medical Virology (June 1995 ・ May 1996).
Reproductive Biology
At the Institute for Research in Reproduction, Bombay:
Occupational Health
・
Training Course on Techniques in Human Semenology
(May 15 - June 2, 1995).
At the- National Institute of Occupational Health,
Ahmedabad:
•
Training Course on Techniques in Immunology, Cell
Biology and Molecular Biology (November 2-25,1995).
・
Training Course on Techniques in Neuroendocrine Re
search (February 6-10, 1996).
•
Training Course on Pesticide Residue Analysis (February 6-17. 1995).
・
Orientation Course on Occupational Health fbr Indus
trial Medical Officers (November 13-24, 1995).、
•
Training Course on Air Pollution^Monitoring and Risk
Assessment (December 13-19, 1995).
Endocrinology
Medical Entomology
At the National Institute of Nutrition, Hyderabad:
At the Vector Control Research Centre .Pondicherry:
•
Annual" Training Course on Endocrinological Tech
niques and their Application (August/September, 1995).
•
M.Sc. in Medical Entomology (From August 1995: fbr
2 years).
Laboratory Animal Technology
Nutrition
At the National Institute of Nutrition, Hyderabad:
•
30
M.Sc. in Applied Nutrition (June 1, 1995 - February
28, 1996).
At the Laboratory Animal Information Services Centre,
National Institute of Nutrition , Hyderabad:
•
Training Course fbr Laboratory Animal Technicians
(June - July, 1995).
ICMR PUBLICATIONS
Price
Rs.
Nutritive Value of Indian Foods (1985), by C. Gopalan, B.V Ramasastri and
S.C. Balasubramaniam, Revised and Updated (1989), by B.S. Narasinga Rao,
K.C. Pant and Y.G. Deosthale
21.00
Growth & Physical Development of Indian Infants and Children (1972, Reprinted 1989)
10.00
Studies on Weaning & Supplementary Foods (1974, Reprinted 1986)
6.00
Studies on Pre-School Children (1974, Reprinted 1986)
6.00
A Manual of Nutrition (Second Edition 1974, Reprinted 1992)
4.50
Low Cost Nutritious Supplements (Second Edition 1975, Reprinted 1994)
4.00
Menus for Low Cost Balanced Diets and School Lunch Programmes Suitable
for South India (Third Edition 1977, Reprinted 1991)
4.50
Menus fbr Low Cost Balanced Diets and School Lunch Programmes Suitable
for North India (Second Edition 1977, Reprinted 1994)
4.50
Some Common Indian Recipes and their Nutritive Value (Fourth Edition 1977,
Reprinted 1991) by Swaran Pasricha & L.M. Rebello
10.00
Nutrition for Mother & Child (Third Edition 1978., Reprinted 1991) by
P.S. Venkatachai am & L.M. Rebello
9.00
Japanese Encephalitis in India (Revised Edition 1980)
5.00
Some Therapeutic Diets (Fourth Edition 1988, Reprinted 1992) by Swaran Pasricha
4.50
Nutrient Requirements & Recommended Dietary Allowances fbr Indians
(1990, Reprinted 1992)
13.00
Fruits (1983, Reprinted 1992) by Indira Gopalan & M. Mohan Ram
7.00
Count What Ybu Eat (1989, Reprinted 1991) by Swaran Pasricha
9.00
Diet & Diabetes (Second Edition 1993) by T.C. Raghuram, Swaran Pasricha,
& R.D. Sharma
18.00
Dietary Tips fbr the Elderly (1990, by Swaran Pasricha & B.V.S. Thimmayamma
3.50
Diet and Heart Disease (1994) by Ghafoorunissa and Kamala Krishnaswamy
26.00
*Depressive Disease (1986) by A. Venkoba Rao
58.00
"Medicinal Plants of India Vol.2 (1987)
136.00
**The Anophelines of India (Revised Edition 1984) by T. Ramachandra Rao
150.00
*10 per cent discount allowed to individuals.
25
***
per cent discount allowed to individuals.
These publications are available on prepayment of cost by cheque, ban^ draft or .postal order (bank and postal charages
will be extra) in favour of the Director-Genera1, Indian Council of Medical Research, New Delhi. Money orders are not
acceptable. All correspondence in this regard should be addressed to the Chief, Division of Publication and Information,
Indian Council of Medical Research, Post Box No.4911, Ansari Nagar, New Delhi-110029 (India).
31
;•
..
•
-v < •
t
( V
\ INDIAN
COUNCIL OF MEDICAL RESEARCH
r
•
Graht-in-aid for organising Seminars/SymposiaAVorkshops
The Council provides partial financial assistance for organising Seminars/Symposia/WorkshOps. Applications for grant
of financial assistance (complete in all respects in the prescribed proforma), will be considered only if furnished at
least four months before the date of commencement of the Seminar/Symposium/Workshop, etc..
Statement about ownership and other particulars of the ICMR Research Information Bulletin as required under
Rule 8 of the Registration of Newspapers (Centarl) Rules 1956.
Place of Publication
Indian Council of Medical Research
Ansari Nagar, New Delhi-110029.
Periodicity of Publication
Monthly
Printer's Name
Shri J.N. Mathur
Nationality
Indian
Address
Press Manager
Indian Council of Medical Research
Ansari Nagar, New Delhi-110029.
Publisher's Name
Nationality
Address
Same as above
Editor's Name
Dr. N. Medappa
Nationality
Indian
Address
Indian Council of Medical Research
Ansari Nagar, New Delhi-110029.
I, J.N. Mathur, hereby declare that the particulars given above are true to the best of my knowledge and
belief.
Sd/- J.N. Mathur
Publisher
Editorial Board
Chairperson
Members
Dr. G.V. Satyavati
Director-General
Dr. Badri N. Saxena
Dr. C.R. Ramachandran
Editor
■
Dr. N. Medappa
Printed and Published by Shri J.N. Mathur for the Indian Council of Medical Research, New Delhi
at the ICMR Offset Press, New Delhi-110029
R.N. 21813/71
Not viewed